Alison Jane Forgie,Javier Fernando Chaparro Riggers,Edward Roland Lavallie,Chia-Yang Lin,Lidia Mosyak,Andrea Rossi,Thomas John Van Blarcom
申请号：
US14976301
公开号：
US20160311912A1
申请日:
2015.12.21
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention provides antagonizing antibodies that bind to glucagon receptor and methods of using same. The anti-glucagon receptor antibodies can be used therapeutically to lower glucose levels in blood, and can be in the prevention and/or treatment of glucose-related disorders, including diabetes, hyperglycemia, hyperinsulinemia, impaired fasting glucose, impaired glucose tolerance, dyslipidemia, or metabolic syndrome.
